Vitamin D Deficiency in Children: Screening, Repletion Dosing, and Rickets Workup
An original evidence synthesis on who to test, how to dose repletion by age, and how to work up suspected nutritional rickets.
One-Minute Takeaway
Key points on this topic:
- The strongest evidence on vitamin D deficiency in children comes from the 2016 international Global Consensus on nutritional rickets, which defines deficiency as serum 25-hydroxyvitamin D below 30 nmol/L (12 ng/mL) and insufficiency as 30–50 nmol/L.
- International consensus consistently advises against routine screening of healthy children and reserves 25(OH)D testing for those with risk factors or a clinical question about bone health.
- Randomised and consensus-based evidence supports age-stratified repletion: roughly 2,000 IU/day under 12 months and 3,000–6,000 IU/day in older children for at least 12 weeks, always paired with at least 500 mg/day of calcium.
- A rickets workup combines history, examination, an elevated alkaline phosphatase, supportive mineral and PTH results, and a wrist or knee radiograph for confirmation.
Why This Topic Matters
Vitamin D deficiency in children sits at the intersection of three recurring clinical questions: who should be tested, how aggressively to replete, and when to pursue a rickets workup. Each question has been answered differently across guidelines, which creates uncertainty at the point of care.
The clinical stakes are concrete. Severe, sustained deficiency drives nutritional rickets, the most preventable cause of impaired bone mineralisation in growing children. Consequences range from bowing deformities to hypocalcaemic seizures in infancy.
At the same time, indiscriminate 25(OH)D testing and high-dose supplementation carry their own costs, including unnecessary expense, false reassurance, and a small risk of toxicity. A coherent approach to vitamin D deficiency in children must therefore balance under-treatment against over-testing.
Evidence Reviewed
This synthesis draws on international consensus guidance and randomised trials addressing screening, repletion dosing, and rickets management. The anchor is the 2016 Global Consensus, an evidence-graded document produced by experts from eleven international scientific organisations.
The table below compares the major sources by scope, population, and the specific question each one informs. Effect estimates are reported in the synthesis that follows.
| Source | Design | Population (n) | Question Informed |
|---|---|---|---|
| Munns 2016 Global Consensus | Consensus, GRADE-graded systematic review | Infants, children, adolescents (international) | Definitions, screening, repletion doses, calcium |
| Indian Academy of Pediatrics 2021 | Consensus guideline | Indian children (national) | Repletion dosing, route, calcium co-therapy |
| Endocrine Society 2024 | Consensus guideline + systematic review | General population, including children | Against routine testing in low-risk groups |
| Thacher 1999 | RCT | Nigerian children with rickets (n=123) | Calcium vs vitamin D vs combination |
| Aggarwal 2013 | RCT | Indian children with rickets (n=67) | Calcium vs vitamin D vs combination |
| Thacher 2014 | RCT | Nigerian children with rickets (n=72) | Added vitamin D in calcium-deficiency rickets |
| Mittal 2014 (stoss dosing) | RCT | Children with rickets (n=64) | 90,000 IU vs 300,000 IU single dose safety |
| Gallo 2013 (infant dosing) | RCT | Healthy breastfed infants (n=132) | 400 vs 800 vs 1,200 vs 1,600 IU/day |
Sample sizes in the rickets treatment trials are modest, reflecting the practical difficulty of randomising children with an uncommon, often resource-limited condition. This constraint is carried forward into the quality assessment below.
Key Findings by Theme
Thresholds that define vitamin D deficiency in children
The Global Consensus harmonised previously conflicting cut-points. It defines deficiency as 25(OH)D below 30 nmol/L (12 ng/mL), insufficiency as 30–50 nmol/L (12–20 ng/mL), and sufficiency as above 50 nmol/L. These thresholds are anchored to bone outcomes rather than to peak calcium absorption.
The lower bound is mechanistically grounded. A consistent observation across cohorts is that PTH begins to rise as 25(OH)D falls below roughly 34 nmol/L, marking the point where mineral homeostasis is stressed. This inflection underpins the 30 nmol/L deficiency line.
The adult-derived 75 nmol/L (30 ng/mL) target reflects optimisation of calcium absorption and PTH suppression in older populations. In paediatrics, the consensus panel found insufficient evidence that pushing children above 30 ng/mL improves bone mass, and the data that exist are inconsistent. The threshold for deficiency is therefore set where rickets risk rises, not where absorption theoretically peaks.
Yes. The threshold for developing rickets is not fixed by 25(OH)D alone. Where dietary calcium is very low, rickets can develop at higher 25(OH)D levels, and conversely adequate calcium is somewhat protective. The consensus classifies calcium intake above 12 months as sufficient (>500 mg/day), insufficient (300–500 mg/day), or deficient (<300 mg/day).
Screening: a consistent argument against universal testing
Across independent guidelines, the recommendation is concordant: do not screen apparently healthy children. The Global Consensus, the Indian Academy of Pediatrics, and multiple hospital pathways all reserve 25(OH)D testing for children with risk factors or when bone-health optimisation is the goal.
The 2024 Endocrine Society guideline reinforces this position for low-risk populations, finding insufficient evidence that routine testing improves outcomes. Risk factors that do justify testing include limited sun exposure, restrictive diets, malabsorption, dark skin pigmentation, and chronic use of medications that impair vitamin D metabolism.
Clinical Pearl
Repletion dosing for vitamin D deficiency in children
The consensus repletion schedule is age-stratified. Infants under 12 months receive about 2,000 IU/day; children aged 1–12 years receive 3,000–6,000 IU/day; and adolescents over 12 years receive 6,000 IU/day. Each intensive phase runs for at least 90 days.
Maintenance then steps down to 400 IU/day in infants and 600 IU/day in older children. The US Endocrine Society offers a simpler alternative of 2,000 IU/day across age groups in the intensive phase, followed by the same 400–600 IU/day maintenance.
A unifying principle across these regimens is that calcium co-therapy is mandatory, not optional. The consensus advises at least 500 mg/day of elemental calcium, by diet or supplement, regardless of age or weight, to support mineralisation and avoid hungry-bone effects during healing.
| Age | Daily Dose for 90 Days | Single (Stoss) Dose | Maintenance |
|---|---|---|---|
| <3 months | 2,000 IU | Not advised | 400 IU/day |
| 3–12 months | 2,000 IU | 50,000 IU | 400 IU/day |
| >12 months to 12 years | 3,000–6,000 IU | 150,000 IU | 600 IU/day |
| >12 years | 6,000 IU | 300,000 IU | 600 IU/day |
Daily versus single high-dose (stoss) therapy
Daily dosing is the preferred default; stoss therapy is reserved for adherence concerns. Randomised data show comparable radiographic healing across single doses, but with a dose-dependent safety signal that argues for restraint.
In one trial, asymptomatic hypercalcaemia at four weeks occurred more often with larger boluses, affecting a meaningful minority of children at 600,000 IU. A separate RCT found that 90,000 IU matched 300,000 IU for efficacy while producing fewer hypercalcaemia events, supporting the lowest effective bolus.
The role of calcium: rickets is not always vitamin D alone
Three randomised trials reshaped how rickets is conceptualised. In Nigerian and Indian children, combination calcium-plus-vitamin-D therapy produced faster decline in alkaline phosphatase and better radiographic healing than calcium alone or vitamin D alone.
Critically, rickets occurred in some children despite near-normal 25(OH)D when dietary calcium was severely low. This explains why the consensus pairs every repletion course with calcium and why a workup should capture dietary calcium history, not just vitamin D status.
Across the major treatment trials, the consistent signal is that vitamin D and calcium act together: correcting one while ignoring the other slows healing of nutritional rickets.
— Synthesis of Thacher 1999, Aggarwal 2013, and Thacher 2014
Quality & Consistency
The evidence base is uneven across the three clinical questions, and the certainty of each conclusion should be read accordingly.
What the Evidence Does Not Show
Evidence Limitations
- No randomised trial establishes an optimal 25(OH)D target above 30 ng/mL for paediatric bone outcomes; the inconsistent data here are why higher cut-points were not endorsed.
- The treatment RCTs were conducted largely in calcium-deficient, sun-rich populations, so their findings may not transfer directly to high-latitude, calcium-replete children.
- Evidence on doses below 2,000 IU/day for active rickets is sparse, leaving the lower efficacious bound undefined.
- The ideal interval for monitoring serum calcium after stoss dosing is not established by trial data.
- Long-term functional outcomes, such as adult peak bone mass after childhood repletion, are not characterised by randomised evidence.
Practical Implications
The following considerations translate the evidence into practice while respecting its limits. They are framed as evidence-supported options, not prescriptive mandates.
A pragmatic rickets workup sequence
Monitoring Tip
Evidence Grade & Bottom Line
Overall evidence grade: Moderate to Strong. Screening and calcium co-therapy rest on consistent, reproducible evidence; specific repletion regimens rest on consensus synthesis and small randomised trials, so dose particulars may be refined over time.
Bottom Line
- Deficiency is defined at 25(OH)D below 30 nmol/L, a threshold tied to bone outcomes rather than peak calcium absorption.
- Testing should be risk-based; routine screening of healthy children is consistently discouraged across guidelines.
- Repletion is age-stratified and time-limited, and is always paired with at least 500 mg/day of calcium.
- A rickets workup pairs an elevated alkaline phosphatase with a wrist or knee radiograph, supported by mineral and PTH testing.
- The main limitation is that dose specifics and optimal targets derive largely from consensus and small trials, not large paediatric outcome studies.
Article Information & References
- Munns CF, Shaw N, Kiely M, et al. Global Consensus Recommendations on Prevention and Management of Nutritional Rickets. J Clin Endocrinol Metab. 2016;101(2):394–415. DOI: 10.1210/jc.2015-2175
- Gupta P, Dabas A, Seth A, et al. Indian Academy of Pediatrics Revised (2021) Guidelines on Prevention and Treatment of Vitamin D Deficiency and Rickets. Indian Pediatr. 2022;59(2):142–158. DOI: 10.1007/s13312-022-2448-y
- Demay MB, Pittas AG, Bikle DD, et al. Vitamin D for the Prevention of Disease: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2024;109(8):1907–1947. DOI: 10.1210/clinem/dgae290
- Thacher TD, Fischer PR, Pettifor JM, et al. A comparison of calcium, vitamin D, or both for nutritional rickets in Nigerian children. N Engl J Med. 1999;341(8):563–568. DOI: 10.1056/NEJM199908193410803
- Aggarwal V, Seth A, Aneja S, et al. Role of calcium deficiency in development of nutritional rickets in Indian children: a case control study. J Clin Endocrinol Metab. 2012;97(10):3461–3466. DOI: 10.1210/jc.2011-3120
- Thacher TD, Fischer PR, Isichei CO, et al. Vitamin D treatment in calcium-deficiency rickets: a randomised controlled trial. Arch Dis Child. 2014;99(9):807–811. DOI: 10.1136/archdischild-2013-305275
- Mittal H, Rai S, Shah D, et al. 300,000 IU or 600,000 IU of oral vitamin D3 for treatment of nutritional rickets: a randomized controlled trial. Indian Pediatr. 2014;51(4):265–272. DOI: 10.1007/s13312-014-0399-7
- Gallo S, Comeau K, Vanstone C, et al. Effect of different dosages of oral vitamin D supplementation on vitamin D status in healthy breastfed infants: a randomized trial. JAMA. 2013;309(17):1785–1792. DOI: 10.1001/jama.2013.3404
- Atapattu N, Shaw N, Högler W. Relationship between serum 25-hydroxyvitamin D and parathyroid hormone in the search for a biochemical definition of vitamin D deficiency in children. Pediatr Res. 2013;74(5):552–556. DOI: 10.1038/pr.2013.139
- Misra M, Pacaud D, Petryk A, et al. Vitamin D deficiency in children and its management: review of current knowledge and recommendations. Pediatrics. 2008;122(2):398–417. DOI: 10.1542/peds.2007-1894
- Uday S, Högler W. Nutritional rickets and osteomalacia in the twenty-first century: revised concepts, public health, and prevention strategies. Curr Osteoporos Rep. 2017;15(4):293–302. DOI: 10.1007/s11914-017-0383-y
- Carpenter TO, Shaw NJ, Portale AA, et al. Rickets. Nat Rev Dis Primers. 2017;3:17101. DOI: 10.1038/nrdp.2017.101